Northern Trust’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.3M | Sell |
997,055
-21,427
| -2% | -$609K | ﹤0.01% | 1441 |
|
|
2025
Q1 | $30.1M | Sell |
1,018,482
-60,952
| -6% | -$1.8M | ﹤0.01% | 1391 |
|
|
2024
Q4 | $31.4M | Buy |
1,079,434
+108,303
| +11% | +$3.15M | ﹤0.01% | 1422 |
|
|
2024
Q3 | $44.6M | Buy |
971,131
+211,059
| +28% | +$9.69M | 0.01% | 1102 |
|
|
2024
Q2 | $31M | Buy |
760,072
+88,744
| +13% | +$3.63M | 0.01% | 1278 |
|
|
2024
Q1 | $17.1M | Buy |
671,328
+8,460
| +1% | +$216K | ﹤0.01% | 1691 |
|
|
2023
Q4 | $6M | Buy |
662,868
+22,524
| +4% | +$204K | ﹤0.01% | 2391 |
|
|
2023
Q3 | $4.09M | Sell |
640,344
-11,156
| -2% | -$71.2K | ﹤0.01% | 2565 |
|
|
2023
Q2 | $7.23M | Buy |
651,500
+50,093
| +8% | +$556K | ﹤0.01% | 2278 |
|
|
2023
Q1 | $9.23M | Buy |
601,407
+73,552
| +14% | +$1.13M | ﹤0.01% | 2070 |
|
|
2022
Q4 | $11.7M | Buy |
527,855
+46,947
| +10% | +$1.04M | ﹤0.01% | 1895 |
|
|
2022
Q3 | $7.85M | Buy |
480,908
+23,994
| +5% | +$392K | ﹤0.01% | 2161 |
|
|
2022
Q2 | $6.64M | Buy |
456,914
+83,520
| +22% | +$1.21M | ﹤0.01% | 2322 |
|
|
2022
Q1 | $6.9M | Sell |
373,394
-5,847
| -2% | -$108K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $9.01M | Buy |
379,241
+24,011
| +7% | +$571K | ﹤0.01% | 2308 |
|
|
2021
Q3 | $8.75M | Buy |
355,230
+83,960
| +31% | +$2.07M | ﹤0.01% | 2376 |
|
|
2021
Q2 | $6.7M | Sell |
271,270
-16,409
| -6% | -$406K | ﹤0.01% | 2647 |
|
|
2021
Q1 | $6.27M | Buy |
287,679
+95,456
| +50% | +$2.08M | ﹤0.01% | 2605 |
|
|
2020
Q4 | $4.91M | Sell |
192,223
-1,204
| -0.6% | -$30.7K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $5.45M | Buy |
+193,427
| New | +$5.45M | ﹤0.01% | 2488 |
|